COORDINATED CHANGES IN THE TUMOR MICROENVIRONMENT (TME) ARE ASSOCIATED WITH INCREASED RISK OF THERAPEUTIC FAILURE IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL).

A total of 3004 single cell events were acquired using MxIF, of which 55% were classified as B cells, 17% as T cells, 8% as macrophages, and 20% as other cells. B Introduction: b Despite advances, 20%-40% of patients with DLBCL do not achieve remission or relapse after an initial response. COORDINATED CHANGES IN THE TUMOR MICROENVIRONMENT (TME) ARE ASSOCIATED WITH INCREASED RISK OF THERAPEUTIC FAILURE IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL). [Extracted from the article]